Table 9.
Testosterone formulations available in the United States
Formulation | Dose |
---|---|
Intramuscular injections (testosterone enanthate or testosterone cypionate) | 75–100 mg weekly or 150–200 mg every 2 weeks |
Transdermal patches (non-scrotal) | 2.5–7.5 mg applied nightly for 24 h |
Transdermal gels | 5–10 g applied daily to upper arms/shoulders, or abdomen (5–10 mg testosterone systemically absorbed) |
Buccal tablets | 30 mg tablet applied to the buccal mucosa every 12 h |
Subcutaneous pellets | 6–10, 75 mg pellets implanted subcutaneously every 4–6 months |
Oral capsule or tablet (methyl testosterone) | Should not be used for the treatment of hypogonadism because of risk of liver toxicity and hepatocellular carcinoma |